WRF
MRVI icon

Waddell & Reed Financial’s Maravai LifeSciences MRVI Stock Holding History

Waddell & Reed Financial’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		$51.8M Sell
1,452,665
-628,545
-30% -$20.8M 0.11% 225
2020
Q4 		$58.4M Buy
+2,081,210
New +$58M 0.12% 193

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.91B AUM 14.64% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Waddell & Reed Financial's MRVI Position: Q1 2021 in Review

Waddell & Reed Financial reduced its Maravai LifeSciences (MRVI) stake by 30% in Q1 2021, selling an estimated $20.8M and leaving 1,452,665 shares worth $51.8M. The position accounts for 0.11% of the portfolio, ranked #225.

Waddell & Reed Financial first reported a position in MRVI in Q4 2020 and has held it in 2 quarters since. The position peaked at $58.4M in Q4 2020. 144 funds tracked by Wall St. Rank hold MRVI as of Q1 2021.

  • Waddell & Reed Financial held 1,452,665 shares of Maravai LifeSciences worth $51.8M as of Q1 2021.
  • Waddell & Reed Financial sold 628,545 Maravai LifeSciences shares in Q1 2021, an estimated $20.8M.
  • Maravai LifeSciences made up 0.11% of Waddell & Reed Financial's portfolio in Q1 2021, its #225 holding.
  • Waddell & Reed Financial first reported a position in Maravai LifeSciences in Q4 2020 and has held it in 2 quarters since.
  • Waddell & Reed Financial's Maravai LifeSciences position peaked at $58.4M in Q4 2020.
  • 144 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q1 2021.

Based on Waddell & Reed Financial's 13F filing for Q1 2021, filed 12 May 2021.